Fate Therapeutics

+$0.23 (+0.27%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FATE and other ETFs, options, and stocks.

About FATE

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates.

CEO
J. Scott Wolchko
Employees
279
Headquarters
San Diego, California
Founded
2007

FATE Key Statistics

Market Cap
8.10B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
772.68K
High Today
$86.79
Low Today
$83.30
Open Price
$85.67
Volume
680.71K
52 Week High
$121.16
52 Week Low
$29.37

FATE Earnings

-$0.68
-$0.45
-$0.23
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure